Trademarkia Logo

Australia

AU$
Trademark Search
STIM-R (SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING)

View On IPO.GOV.AU

STIM-R (SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING)
Registered: Registered/protected

Last updated on 7 Nov 2022

Owner Info

Lyell Immunopharma, Inc. Delaware

201 Haskins Way

South San Francisco, California, 94080 UNITED STATES OF AMERICA,

Serial Number

2241835 filed on 12 Jan 2022

Correspondent

AJ Park

PO Box 949,

WELLINGTON, 6140 NEW ZEALAND,

STIM-R (SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING)

Classification Information

Class [001]
Chemical, biological and biochemical products for research and scientific purposes; reagents for programmable culturing of biological material other t Read More

Class [005]
Pharmaceutical, medical and veterinary preparations; reagents for the processing and culturing of biological material for medical purposes; chemical, Read More

Class [042]
Scientific and technological services, and biological research and development relating thereto; Medical, pharmaceutical and biotechnological research Read More

Class [044]
Medical services.

Mark Details

Serial Number

2241835

Registered On

12 Jan 2022

Renewal On

12 Jan 2032

Mark Type

WORD

Priority Claim (Convention Details)

Date

21 Jul 2021

Mark Type

US

Legal History

Show more

Status DateAction Taken
7th Nov 2022IP Right Registered correspondence sent
7th Nov 2022IP Right Registration Published
7th Nov 2022Status change to Registered/Protected
30th Aug 2022Application Accepted correspondence sent
30th Aug 2022IP Right has been Examined
30th Aug 2022IP Right Acceptance Published
30th Aug 2022Status change to Accepted
30th Aug 2022IP right goods and service classes updated
30th Aug 2022IP Right Goods and Services Items updated
30th Aug 2022IP Right Goods and Services Items updated